Ji et al. reviewed the significant potential of post-translational modifications of PPARγ in the treatment of T2DM (Ji et al., 2022), suggesting that it may become a promising target for exercise interventions aimed at improving mitochondrial function in T2DM patients. This evidence concerns the gene PPARG and type 2 diabetes mellitus.